{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:17:48Z","timestamp":1790745468604,"version":"4.1.0"},"reference-count":147,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,4,6]],"date-time":"2018-04-06T00:00:00Z","timestamp":1522972800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"DOI":"10.3389\/fcimb.2018.00115","type":"journal-article","created":{"date-parts":[[2018,4,6]],"date-time":"2018-04-06T12:48:14Z","timestamp":1523018894000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":37,"title":["Adaptive Immunity to Francisella tularensis and Considerations for Vaccine Development"],"prefix":"10.3389","volume":"8","author":[{"given":"Lydia M.","family":"Roberts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Frelinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,4,6]]},"reference":[{"key":"B1","volume-title":"Biohazard: The Chilling True Story of the Largest Covert Biological Weapons Program in the World, Told from the Inside by the Man Who Ran It","author":"Alibek","year":"1999"},{"key":"B2","doi-asserted-by":"publisher","first-page":"6562","DOI":"10.1016\/j.vaccine.2010.07.072","article-title":"Long lived protection against pneumonic tularemia is correlated with cellular immunity in peripheral, not pulmonary, organs","volume":"28","author":"Anderson","year":"2010","journal-title":"Vaccine"},{"key":"B3","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/0882-4010(89)90022-3","article-title":"The requirement for gamma interferon in resistance of mice to experimental tularemia","volume":"7","author":"Anthony","year":"1989","journal-title":"Microb. Pathog."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1128\/IAI.00207-13","article-title":"Infection with Francisella tularensis LVS clpB leads to an altered yet protective immune response","volume":"81","author":"Barrigan","year":"2013","journal-title":"Infect. Immun."},{"key":"B5","first-page":"339","article-title":"Pathogenesis and pathology of respiratory tularaemia in the rabbit","volume":"57","author":"Baskerville","year":"1976","journal-title":"Br. J. Exp. Pathol."},{"key":"B6","first-page":"615","article-title":"The pathology of untreated and antibiotic-treated experimental tularaemia in monkeys","volume":"59","author":"Baskerville","year":"1978","journal-title":"Br. J. Exp. Pathol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"16013","DOI":"10.1038\/npjvaccines.2016.13","article-title":"First vaccine approval under the FDA Animal Rule","volume":"1","author":"Beasley","year":"2016","journal-title":"NPJ Vaccines"},{"key":"B8","doi-asserted-by":"publisher","first-page":"4538","DOI":"10.4049\/jimmunol.178.7.4538","article-title":"Active suppression of the pulmonary immune response by Francisella tularensis Schu4","volume":"178","author":"Bosio","year":"2007","journal-title":"J. Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"564","DOI":"10.7589\/2015-02-030","article-title":"Pathogenesis and immune responses of Francisella Tularensis strains in wild-caught cottontail rabbits (Sylvilagus spp.)","volume":"51","author":"Brown","year":"","journal-title":"J. Wildl. Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e0140723","DOI":"10.1371\/journal.pone.0140723","article-title":"Prior inoculation with Type B Strains of Francisella tularensis provides partial protection against virulent type A strains in cottontail rabbits","volume":"10","author":"Brown","year":"","journal-title":"PLoS ONE"},{"key":"B11","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1093\/infdis\/135.1.55","article-title":"Immunization against tularemia: analysis of the effectiveness of live Francisella tularensis vaccine in prevention of laboratory-acquired tularemia","volume":"135","author":"Burke","year":"1977","journal-title":"J. Infect. Dis."},{"key":"B12","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1128\/JCM.10.5.615-621.1979","article-title":"Enzyme-linked immunosorbent assay for immunological diagnosis of human tularemia","volume":"10","author":"Carlsson","year":"1979","journal-title":"J. Clin. Microbiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.micpath.2004.02.003","article-title":"Susceptibility of immunodeficient mice to aerosol and systemic infection with virulent strains of Francisella tularensis","volume":"36","author":"Chen","year":"2004","journal-title":"Microb. Pathog."},{"key":"B14","doi-asserted-by":"publisher","first-page":"3690","DOI":"10.1016\/S0264-410X(03)00386-4","article-title":"Tularemia in BALB\/c and C57BL\/6 mice vaccinated with Francisella tularensis LVS and challenged intradermally, or by aerosol with virulent isolates of the pathogen: protection varies depending on pathogen virulence, route of exposure, and host genetic background","volume":"21","author":"Chen","year":"2003","journal-title":"Vaccine"},{"key":"B15","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1001\/jama.1997.03550050074036","article-title":"Biological warfare. A historical perspective","volume":"278","author":"Christopher","year":"1997","journal-title":"JAMA"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e1004439","DOI":"10.1371\/journal.ppat.1004439","article-title":"Live attenuated Francisella novicida vaccine protects against Francisella tularensis pulmonary challenge in rats and non-human primates","volume":"10","author":"Chu","year":"2014","journal-title":"PLoS Pathog."},{"key":"B17","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1128\/JCM.34.8.1995-2000.1996","article-title":"Characterization of two unusual clinically significant Francisella strains","volume":"34","author":"Clarridge","year":"1996","journal-title":"J. Clin. Microbiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1189\/jlb.0111014","article-title":"Role of TLR signaling in Francisella tularensis-LPS-induced, antibody-mediated protection against Francisella tularensis challenge","volume":"90","author":"Cole","year":"2011","journal-title":"J. Leukoc. Biol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1128\/IAI.01322-08","article-title":"T cells from lungs and livers of Francisella tularensis-immune mice control the growth of intracellular bacteria","volume":"77","author":"Collazo","year":"2009","journal-title":"Infect. Immun."},{"key":"B20","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.micinf.2005.09.014","article-title":"Myeloid differentiation factor-88 (MyD88) is essential for control of primary in vivo Francisella tularensis LVS infection, but not for control of intra-macrophage bacterial replication","volume":"8","author":"Collazo","year":"2006","journal-title":"Microbes Infect."},{"key":"B21","doi-asserted-by":"publisher","first-page":"391","DOI":"10.2217\/fmb.11.22","article-title":"Tularemia vaccines: recent developments and remaining hurdles","volume":"6","author":"Conlan","year":"2011","journal-title":"Future Microbiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0882-4010(03)00046-9","article-title":"Experimental tularemia in mice challenged by aerosol or intradermally with virulent strains of Francisella tularensis: bacteriologic and histopathologic studies","volume":"34","author":"Conlan","year":"2003","journal-title":"Microb. Pathog."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1016\/j.vaccine.2009.12.001","article-title":"Differential ability of novel attenuated targeted deletion mutants of Francisella tularensis subspecies tularensis strain SCHU S4 to protect mice against aerosol challenge with virulent bacteria: effects of host background and route of immunization","volume":"28","author":"Conlan","year":"2010","journal-title":"Vaccine"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1016\/j.vaccine.2004.10.034","article-title":"Aerosol-, but not intradermal-immunization with the live vaccine strain of Francisella tularensis protects mice against subsequent aerosol challenge with a highly virulent type A strain of the pathogen by an alphabeta T cell- and interferon gamma- dependent mechanism","volume":"23","author":"Conlan","year":"2005","journal-title":"Vaccine"},{"key":"B25","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1084\/jem.20030687","article-title":"Multiple T cell subsets control Francisella tularensis LVS intracellular growth without stimulation through macrophage interferon gamma receptors","volume":"198","author":"Cowley","year":"2003","journal-title":"J. Exp. Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1084\/jem.20050569","article-title":"CD4-CD8- T cells control intracellular bacterial infections both in vitro and in vivo","volume":"202","author":"Cowley","year":"2005","journal-title":"J. Exp. Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"5791","DOI":"10.4049\/jimmunol.1000362","article-title":"Lung CD4-CD8- double-negative T cells are prominent producers of IL-17A and IFN-gamma during primary respiratory murine infection with Francisella tularensis live vaccine strain","volume":"184","author":"Cowley","year":"2010","journal-title":"J. Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.4049\/jimmunol.1202697","article-title":"B1a cells enhance susceptibility to infection with virulent Francisella tularensis via modulation of NK\/NKT cell responses","volume":"190","author":"Crane","year":"","journal-title":"J. Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1128\/CVI.00319-13","article-title":"Lipids derived from virulent Francisella tularensis broadly inhibit pulmonary inflammation via toll-like receptor 2 and peroxisome proliferator-activated receptor \u03b1","volume":"20","author":"Crane","year":"","journal-title":"Clin. Vaccine Immunol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e33349","DOI":"10.1371\/journal.pone.0033349","article-title":"Generation of a convalescent model of virulent Francisella tularensis infection for assessment of host requirements for survival of tularemia","volume":"7","author":"Crane","year":"2012","journal-title":"PLoS ONE"},{"key":"B31","doi-asserted-by":"publisher","first-page":"130002","DOI":"10.1098\/rsob.130002","article-title":"Exploitation of bacterial N-linked glycosylation to develop a novel recombinant glycoconjugate vaccine against Francisella tularensis","volume":"3","author":"Cuccui","year":"2013","journal-title":"Open Biol."},{"key":"B32","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.4049\/jimmunol.158.7.3277","article-title":"A novel role for B cells in early protective immunity to an intracellular pathogen, Francisella tularensis strain LVS","volume":"158","author":"Culkin","year":"1997","journal-title":"J. Immunol."},{"key":"B33","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1128\/IAI.5.1.77-82.1972","article-title":"Experimental tularemia in Macaca mulatta: relationship of aerosol particle size to the infectivity of airborne Pasteurella tularensis","volume":"5","author":"Day","year":"1972","journal-title":"Infect. Immun."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1001\/jama.285.21.2763","article-title":"Tularemia as a biological weapon: medical and public health management","volume":"285","author":"Dennis","year":"2001","journal-title":"JAMA"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e1002494","DOI":"10.1371\/journal.ppat.1002494","article-title":"Development of functional and molecular correlates of vaccine-induced protection for a model intracellular pathogen, F. tularensis LVS","volume":"8","author":"De Pascalis","year":"2012","journal-title":"PLoS Pathog."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e00936","DOI":"10.1128\/mBio.00936-13","article-title":"Models derived from in vitro analyses of spleen, liver, and lung leukocyte functions predict vaccine efficacy against the Francisella tularensis Live Vaccine Strain (LVS)","volume":"5","author":"De Pascalis","year":"2014","journal-title":"MBio"},{"key":"B37","doi-asserted-by":"crossref","first-page":"217","DOI":"10.4049\/jimmunol.56.3.217","article-title":"Studies on tularemia; the comparative susceptibility of various laboratory animals","volume":"56","author":"Downs","year":"1947","journal-title":"J. Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1128\/IAI.68.4.1988-1996.2000","article-title":"Purified lipopolysaccharide from Francisella tularensis live vaccine strain (LVS) induces protective immunity against LVS infection that requires B cells and gamma interferon","volume":"68","author":"Dreisbach","year":"2000","journal-title":"Infect. Immun."},{"key":"B39","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1099\/mic.0.031716-0","article-title":"Restricted cytosolic growth of Francisella tularensis subsp. tularensis by IFN-gamma activation of macrophages","volume":"156","author":"Edwards","year":"2010","journal-title":"Microbiology"},{"key":"B40","doi-asserted-by":"crossref","first-page":"415","DOI":"10.4049\/jimmunol.87.4.415","article-title":"Prophylactic effectiveness of live and killed tularemia vaccines. I. Production of vaccine and evaluation in the white mouse and guinea pig","volume":"87","author":"Eigelsbach","year":"1961","journal-title":"J. Immunol."},{"key":"B41","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1128\/JB.84.5.1020-1027.1962","article-title":"Live tularemia vaccine I. : host-parasite relationship in monkeys vaccinated intracutaneously or aerogenically","volume":"84","author":"Eigelsbach","year":"1962","journal-title":"J. Bacteriol."},{"key":"B42","doi-asserted-by":"crossref","first-page":"6002","DOI":"10.1128\/IAI.67.11.6002-6007.1999","article-title":"Importance of B cells, but not specific antibodies, in primary and secondary protective immunity to the intracellular bacterium Francisella tularensis live vaccine strain","volume":"67","author":"Elkins","year":"1999","journal-title":"Infect. Immun."},{"key":"B43","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1128\/IAI.61.3.823-829.1993","article-title":"T-cell-independent resistance to infection and generation of immunity to Francisella tularensis","volume":"61","author":"Elkins","year":"1993","journal-title":"Infect. Immun."},{"key":"B44","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1128\/IAI.64.8.3288-3293.1996","article-title":"Minimal requirements for murine resistance to infection with Francisella tularensis LVS","volume":"64","author":"Elkins","year":"1996","journal-title":"Infect. Immun."},{"key":"B45","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1128\/CMR.15.4.631-646.2002","article-title":"Tularemia","volume":"15","author":"Ellis","year":"2002","journal-title":"Clin. Microbiol. Rev."},{"key":"B46","doi-asserted-by":"publisher","first-page":"e32367","DOI":"10.1371\/journal.pone.0032367","article-title":"Signatures of T cells as correlates of immunity to Francisella tularensis","volume":"7","author":"Enesl\u00e4tt","year":"2012","journal-title":"PLoS ONE"},{"key":"B47","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1093\/infdis\/170.1.110","article-title":"Persistence of cell-mediated immunity and decline of humoral immunity to the intracellular bacterium Francisella tularensis 25 years after natural infection","volume":"170","author":"Ericsson","year":"1994","journal-title":"J. Infect. Dis."},{"key":"B48","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/00005792-198507000-00006","article-title":"Tularemia: a 30-year experience with 88 cases","volume":"64","author":"Evans","year":"1985","journal-title":"Medicine"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1002\/pmic.200600985","article-title":"Immunodominant Francisella tularensis antigens identified using proteome microarray","volume":"7","author":"Eyles","year":"2007","journal-title":"Proteomics"},{"key":"B50","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1086\/518611","article-title":"Francisella tularensis has a significant extracellular phase in infected mice","volume":"196","author":"Forestal","year":"2007","journal-title":"J. Infect. Dis."},{"key":"B51","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1128\/IAI.60.3.817-825.1992","article-title":"Activation of macrophages for destruction of Francisella tularensis: identification of cytokines, effector cells, and effector molecules","volume":"60","author":"Fortier","year":"1992","journal-title":"Infect. Immun."},{"key":"B52","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1128\/IAI.59.9.2922-2928.1991","article-title":"Live vaccine strain of Francisella tularensis: infection and immunity in mice","volume":"59","author":"Fortier","year":"1991","journal-title":"Infect. Immun."},{"key":"B53","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1146\/annurev.mi.04.100150.001525","article-title":"Tularemia","volume":"4","author":"Foshay","year":"1950","journal-title":"Annu. Rev. Microbiol."},{"key":"B54","first-page":"577","article-title":"Tularemia: the microscopic changes of the lesions in man","volume":"3","author":"Francis","year":"1927","journal-title":"Arch. Pathol. Lab. Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"4465","DOI":"10.1016\/S0264-410X(01)00189-X","article-title":"Role of antibody to lipopolysaccharide in protection against low- and high-virulence strains of Francisella tularensis","volume":"19","author":"Fulop","year":"2001","journal-title":"Vaccine"},{"key":"B56","doi-asserted-by":"publisher","first-page":"44","DOI":"10.2307\/4583978","article-title":"Antitularemic serum","volume":"57","author":"Francis","year":"1942","journal-title":"Public Health Rep."},{"key":"B57","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3389\/fcimb.2014.00045","article-title":"Virulent type A Francisella tularensis actively suppresses cytokine responses in human monocytes","volume":"4","author":"Gillette","year":"2014","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B58","first-page":"61","article-title":"Tularemia pneumonia","volume":"12","author":"Gill","year":"1997","journal-title":"Semin. Respir. Infect."},{"key":"B59","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.cimid.2015.01.003","article-title":"Comparison of experimental respiratory tularemia in three nonhuman primate species","volume":"39","author":"Glynn","year":"2015","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"B60","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/0264-410X(95)93311-V","article-title":"Adjuvanticity of ISCOMs incorporating a T cell-reactive lipoprotein of the facultative intracellular pathogen Francisella tularensis","volume":"13","author":"Golovliov","year":"1995","journal-title":"Vaccine"},{"key":"B61","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3389\/fcimb.2016.00152","article-title":"An in vitro co-culture mouse model demonstrates efficient vaccine-mediated control of Francisella tularensis SCHU S4 and identifies nitric oxide as a predictor of efficacy","volume":"6","author":"Golovliov","year":"2016","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1128\/CVI.00648-14","article-title":"Successful protection against tularemia in C57BL\/6 mice is correlated with expansion of Francisella tularensis-specific effector T cells","volume":"22","author":"Griffin","year":"2015","journal-title":"Clin. Vaccine Immunol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1369\/jhc.5R6756.2005","article-title":"Histopathology and immunohistochemistry in the diagnosis of bioterrorism agents","volume":"54","author":"Guarner","year":"2006","journal-title":"J. Histochem. Cytochem."},{"key":"B64","first-page":"630","article-title":"Changes in whole blood and serum components of grivet monkeys with experimental respiratory Francisella tularensis infection","volume":"59","author":"Hambleton","year":"1978","journal-title":"Br. J. Exp. Pathol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1002\/1615-9861(200207)2:7>857::AID-PROT857<3.0.CO;2-L","article-title":"Mapping of immunoreactive antigens of Francisella tularensis live vaccine strain","volume":"2","author":"Havlasov\u00e1","year":"2002","journal-title":"Proteomics"},{"key":"B66","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1128\/MMBR.30.3.532-538.1966","article-title":"Aerogenic immunization of man with live Tularemia vaccine","volume":"30","author":"Hornick","year":"1966","journal-title":"Bacteriol. Rev."},{"key":"B67","doi-asserted-by":"publisher","first-page":"3664","DOI":"10.1128\/IAI.00374-08","article-title":"Native outer membrane proteins protect mice against pulmonary challenge with virulent type A Francisella tularensis","volume":"76","author":"Huntley","year":"2008","journal-title":"Infect. Immun."},{"key":"B68","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.ajpath.2016.09.021","article-title":"The natural history of pneumonic Tularemia in female Fischer 344 rats after inhalational exposure to aerosolized Francisella tularensis subspecies Tularensis strain SCHU S4","volume":"187","author":"Hutt","year":"2017","journal-title":"Am. J. Pathol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/BF02932159","article-title":"Proteomic analysis of antibody response in a case of laboratory-acquired infection with Francisella tularensis subsp. tularensis","volume":"52","author":"Janovsk\u00e1","year":"2007","journal-title":"Folia Microbiol."},{"key":"B70","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1128\/JCM.38.1.22-26.2000","article-title":"Comparative analysis of PCR versus culture for diagnosis of ulceroglandular tularemia","volume":"38","author":"Johansson","year":"2000","journal-title":"J. Clin. Microbiol."},{"key":"B71","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1128\/JCM.29.4.753-756.1991","article-title":"Francisella tularensis-induced in vitro gamma interferon, tumor necrosis factor alpha, and interleukin 2 responses appear within 2 weeks of tularemia vaccination in human beings","volume":"29","author":"Karttunen","year":"1991","journal-title":"J. Clin. Microbiol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3389\/fmicb.2010.00143","article-title":"The Francisella tularensis proteome and its recognition by antibodies","volume":"1","author":"Kilmury","year":"2010","journal-title":"Front. Microbiol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"532","DOI":"10.4049\/jimmunol.179.1.532","article-title":"Prophylactic and therapeutic use of antibodies for protection against respiratory infection with Francisella tularensis","volume":"179","author":"Kirimanjeswara","year":"2007","journal-title":"J. Immunol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.1600-065X.2008.00689.x","article-title":"Humoral and cell-mediated immunity to the intracellular pathogen Francisella tularensis","volume":"225","author":"Kirimanjeswara","year":"2008","journal-title":"Immunol. Rev."},{"key":"B75","doi-asserted-by":"publisher","first-page":"6874","DOI":"10.1016\/j.vaccine.2008.09.077","article-title":"Levofloxacin rescues mice from lethal intra-nasal infections with virulent Francisella tularensis and induces immunity and production of protective antibody","volume":"26","author":"Klimpel","year":"2008","journal-title":"Vaccine"},{"key":"B76","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/0264-410X(85)90129-X","article-title":"Humoral immunity induced by a live Francisella tularensis vaccine. Complement fixing antibodies determined by an enzyme-linked immunosorbent assay (CF-ELISA)","volume":"3","author":"Koskela","year":"1985","journal-title":"Vaccine"},{"key":"B77","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1128\/IAI.36.3.983-989.1982","article-title":"Cell-mediated and humoral immunity induced by a live Francisella tularensis vaccine","volume":"36","author":"Koskela","year":"1982","journal-title":"Infect. Immun."},{"key":"B78","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1128\/JCM.22.6.973-979.1985","article-title":"Humoral immunity against Francisella tularensis after natural infection","volume":"22","author":"Koskela","year":"1985","journal-title":"J. Clin. Microbiol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1046\/j.1365-2249.2000.01215.x","article-title":"The proportion of circulating gammadelta T cells increases after the first week of onset of tularaemia and remains elevated for more than a year","volume":"120","author":"Kroca","year":"2000","journal-title":"Clin. Exp. Immunol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"3781","DOI":"10.1016\/j.vaccine.2007.02.014","article-title":"Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis","volume":"25","author":"KuoLee","year":"2007","journal-title":"Vaccine"},{"key":"B81","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/modpathol.3800087","article-title":"Histologic and molecular diagnosis of tularemia: a potential bioterrorism agent endemic to North America","volume":"17","author":"Lamps","year":"2004","journal-title":"Mod. Pathol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"4246","DOI":"10.1073\/pnas.0307690101","article-title":"MglA regulates transcription of virulence factors necessary for Francisella tularensis intraamoebae and intramacrophage survival","volume":"101","author":"Lauriano","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B83","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1002\/eji.200737620","article-title":"Immunization with heat-killed Francisella tularensis LVS elicits protective antibody-mediated immunity","volume":"37","author":"Lavine","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"B84","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1128\/IAI.60.1.84-89.1992","article-title":"In vivo modulation of the murine immune response to Francisella tularensis LVS by administration of anticytokine antibodies","volume":"60","author":"Leiby","year":"1992","journal-title":"Infect. Immun."},{"key":"B85","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.immuni.2009.08.025","article-title":"Interleukin-17 is required for T helper 1 cell immunity and host resistance to the intracellular pathogen Francisella tularensis","volume":"31","author":"Lin","year":"2009","journal-title":"Immunity"},{"key":"B86","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.imlet.2007.07.006","article-title":"Generation and characterization of hybridoma antibodies for immunotherapy of tularemia","volume":"112","author":"Lu","year":"2007","journal-title":"Immunol. Lett."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1128\/IAI.00605-10","article-title":"Antibodies contribute to effective vaccination against respiratory infection by type A Francisella tularensis strains","volume":"79","author":"Mara-Koosham","year":"2011","journal-title":"Infect Immun"},{"key":"B88","doi-asserted-by":"publisher","first-page":"e11176","DOI":"10.1371\/journal.pone.0011176","article-title":"The involvement of IL-17A in the murine response to sub-lethal inhalational infection with Francisella tularensis","volume":"5","author":"Markel","year":"2010","journal-title":"PLoS ONE"},{"key":"B89","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.1016\/j.vaccine.2013.05.096","article-title":"Live attenuated tularemia vaccines: recent developments and future goals","volume":"31","author":"Marohn","year":"2013","journal-title":"Vaccine"},{"key":"B90","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1128\/MMBR.25.3.262-267.1961","article-title":"Aerosol infection of man with Pasteurella Tularensis","volume":"25","author":"McCrumb","year":"1961","journal-title":"Bacteriol. Rev."},{"key":"B91","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.1016\/j.vaccine.2007.01.039","article-title":"Diversity of Francisella tularensis Schu4 antigens recognized by T lymphocytes after natural infections in humans: identification of candidate epitopes for inclusion in a rationally designed tularemia vaccine","volume":"25","author":"McMurry","year":"2007","journal-title":"Vaccine"},{"key":"B92","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1084\/jem.20160637","article-title":"MAIT cells promote inflammatory monocyte differentiation into dendritic cells during pulmonary intracellular infection","volume":"213","author":"Meierovics","year":"2016","journal-title":"J. Exp. Med."},{"key":"B93","doi-asserted-by":"publisher","first-page":"E3119","DOI":"10.1073\/pnas.1302799110","article-title":"MAIT cells are critical for optimal mucosal immune responses during in vivo pulmonary bacterial infection","volume":"110","author":"Meierovics","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1099\/jmm.0.020669-0","article-title":"Characterization of lethal inhalational infection with Francisella tularensis in the common marmoset (Callithrix jacchus)","volume":"59","author":"Nelson","year":"2010","journal-title":"J. Med. Microbiol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/j.1365-2613.2008.00631.x","article-title":"Establishment of lethal inhalational infection with Francisella tularensis (tularaemia) in the common marmoset (Callithrix jacchus)","volume":"90","author":"Nelson","year":"2009","journal-title":"Int. J. Exp. Pathol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1093\/jmedent\/35.4.471","article-title":"Arthropod-borne tularemia in Japan: clinical analysis of 1,374 cases observed between 1924 and 1996","volume":"35","author":"Ohara","year":"1998","journal-title":"J. Med. Entomol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1128\/IAI.74.4.2063-2071.2006","article-title":"Intranasal vaccination with a defined attenuated Francisella novicida strain induces gamma interferon-dependent antibody-mediated protection against tularemia","volume":"74","author":"Pammit","year":"2006","journal-title":"Infect. Immun."},{"key":"B98","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1089\/jir.2009.0108","article-title":"Th17 cytokines in recall responses against Francisella tularensis in humans","volume":"30","author":"Paranavitana","year":"2010","journal-title":"J. Interferon Cytokine Res."},{"key":"B99","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/nyas.13126","article-title":"Working with the U.S. Food and Drug Administration to obtain approval of products under the animal rule","volume":"1374","author":"Park","year":"2016","journal-title":"Ann. N Y Acad. Sci."},{"key":"B100","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1016\/j.vaccine.2008.01.005","article-title":"An improved Francisella tularensis live vaccine strain (LVS) is well tolerated and highly immunogenic when administered to rabbits in escalating doses using various immunization routes","volume":"26","author":"Pasetti","year":"2008","journal-title":"Vaccine"},{"key":"B101","doi-asserted-by":"publisher","first-page":"e2487","DOI":"10.1371\/journal.pone.0002487","article-title":"A Francisella tularensis Schu S4 purine auxotroph is highly attenuated in mice but offers limited protection against homologous intranasal challenge","volume":"3","author":"Pechous","year":"2008","journal-title":"PLoS ONE"},{"key":"B102","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.4049\/jimmunol.153.3.1238","article-title":"Nitric oxide-independent killing of Francisella tularensis by IFN-gamma-stimulated murine alveolar macrophages","volume":"153","author":"Polsinelli","year":"1994","journal-title":"J. Immunol."},{"key":"B103","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1128\/IAI.66.5.2107-2114.1998","article-title":"Expansion of Vgamma9 Vdelta2 T cells is triggered by Francisella tularensis-derived phosphoantigens in tularemia but not after tularemia vaccination","volume":"66","author":"Poquet","year":"1998","journal-title":"Infect. Immun."},{"key":"B104","doi-asserted-by":"publisher","first-page":"5548","DOI":"10.4049\/jimmunol.180.8.5548","article-title":"Utilization of Fc receptors as a mucosal vaccine strategy against an intracellular bacterium, Francisella tularensis","volume":"180","author":"Rawool","year":"2008","journal-title":"J. Immunol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"e9952","DOI":"10.1371\/journal.pone.0009952","article-title":"The Fischer 344 rat reflects human susceptibility to Francisella pulmonary challenge and provides a new platform for virulence and protection studies","volume":"5","author":"Ray","year":"2010","journal-title":"PLoS ONE"},{"key":"B106","doi-asserted-by":"publisher","first-page":"e24654","DOI":"10.1371\/journal.pone.0024654","article-title":"Pneumonic tularemia in rabbits resembles the human disease as illustrated by radiographic and hematological changes after infection","volume":"6","author":"Reed","year":"2011","journal-title":"PLoS ONE"},{"key":"B107","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1128\/IAI.01498-14","article-title":"Live attenuated mutants of Francisella tularensis protect rabbits against aerosol challenge with a virulent type A strain","volume":"82","author":"Reed","year":"2014","journal-title":"Infect. Immun."},{"key":"B108","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1128\/IAI.62.8.3129-3137.1994","article-title":"Transfer of immunity against lethal murine Francisella infection by specific antibody depends on host gamma interferon and T cells","volume":"62","author":"Rhinehart-Jones","year":"1994","journal-title":"Infect. Immun."},{"key":"B109","doi-asserted-by":"publisher","first-page":"e00574-16","DOI":"10.1128\/CVI.00574-16","article-title":"Monophosphoryl lipid A enhances efficacy of a Francisella tularensis LVS-catanionic nanoparticle subunit vaccine against F. tularensis Schu S4 challenge by augmenting both humoral and cellular immunity","volume":"24","author":"Richard","year":"2017","journal-title":"Clin. Vaccine Immunol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1128\/CVI.00738-13","article-title":"Novel catanionic surfactant vesicle vaccines protect against Francisella tularensis LVS and confer significant partial protection against F. tularensis Schu S4 strain","volume":"21","author":"Richard","year":"2014","journal-title":"Clin. Vaccine Immunol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.4049\/jimmunol.1600879","article-title":"Inclusion of epitopes that expand high-avidity CD4+ T cells transforms subprotective vaccines to efficacious immunogens against virulent Francisella tularensis","volume":"197","author":"Roberts","year":"2016","journal-title":"J. Immunol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"3595","DOI":"10.1016\/j.vaccine.2014.05.013","article-title":"IFN-gamma, but not IL-17A, is required for survival during secondary pulmonary Francisella tularensis live vaccine stain infection","volume":"32","author":"Roberts","year":"2014","journal-title":"Vaccine"},{"key":"B113","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1016\/j.vaccine.2017.03.064","article-title":"Expansion and retention of pulmonary CD4+ T cells after prime boost vaccination correlates with improved longevity and strength of immunity against tularemia","volume":"35","author":"Roberts","year":"2017","journal-title":"Vaccine"},{"key":"B114","doi-asserted-by":"publisher","first-page":"e85215","DOI":"10.1371\/journal.pone.0085215","article-title":"Protective immunity against lethal F. tularensis holarctica LVS provided by vaccination with selected novel CD8+ T cell epitopes","volume":"9","author":"Rotem","year":"2014","journal-title":"PLoS ONE"},{"key":"B115","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.micinf.2012.02.001","article-title":"Peripheral human gammadelta T cells control growth of both avirulent and highly virulent strains of Francisella tularensis in vitro","volume":"14","author":"Rowland","year":"2012","journal-title":"Microbes Infect."},{"key":"B116","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.vaccine.2009.09.100","article-title":"Generation of heterogeneous memory T cells by live attenuated tularemia vaccine in humans","volume":"28","author":"Salerno-Gon\u00e7alves","year":"2009","journal-title":"Vaccine"},{"key":"B117","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1128\/IAI.00036-12","article-title":"Perforin- and granzyme-mediated cytotoxic effector functions are essential for protection against Francisella tularensis following vaccination by the defined F. tularensis subsp. novicida DeltafopC vaccine strain","volume":"80","author":"Sanapala","year":"2012","journal-title":"Infect. Immun."},{"key":"B118","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1001\/archinte.1961.03620050068007","article-title":"Tularemia vaccine study. II. Respiratory challenge","volume":"107","author":"Saslaw","year":"","journal-title":"Arch. Intern. Med."},{"key":"B119","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1001\/archinte.1961.03620050055006","article-title":"Tularemia vaccine study. I. Intracutaneous challenge","volume":"107","author":"Saslaw","year":"","journal-title":"Arch. Intern. Med."},{"key":"B120","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1128\/MMBR.30.3.542-550.1966","article-title":"Antibiotic prophylaxis and therapy of airborne tularemia","volume":"30","author":"Sawyer","year":"1966","journal-title":"Bacteriol. Rev."},{"key":"B121","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1128\/IAI.01789-06","article-title":"A defined O-antigen polysaccharide mutant of Francisella tularensis live vaccine strain has attenuated virulence while retaining its protective capacity","volume":"75","author":"Sebastian","year":"2007","journal-title":"Infect. Immun."},{"key":"B122","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1016\/j.vaccine.2003.12.003","article-title":"Susceptibility of various mouse strains to systemically- or aerosol-initiated tularemia by virulent type A Francisella tularensis before and after immunization with the attenuated live vaccine strain of the pathogen","volume":"22","author":"Shen","year":"2004","journal-title":"Vaccine"},{"key":"B123","doi-asserted-by":"publisher","first-page":"e47639","DOI":"10.1371\/journal.pone.0047639","article-title":"Mucosal immunization with live attenuated Francisella novicida U112DeltaiglB protects against pulmonary F. tularensis SCHU S4 in the Fischer 344 rat model","volume":"7","author":"Signarovitz","year":"2012","journal-title":"PLoS ONE"},{"key":"B124","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1099\/13500872-142-6-1369","article-title":"The requirement of tumour necrosis factor-alpha and interferon-gamma for the expression of protective immunity to secondary murine tularaemia depends on the size of the challenge inoculum","volume":"142","author":"Sj\u00f6stedt","year":"1996","journal-title":"Microbiology"},{"key":"B125","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1128\/IAI.00203-13","article-title":"Interleukin-17 protects against the Francisella tularensis live vaccine strain but not against a virulent F. tularensis type A strain","volume":"81","author":"Skyberg","year":"2013","journal-title":"Infect. Immun."},{"key":"B126","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0882-4010(03)00095-0","article-title":"Specific antibodies contribute to the host protection against strains of Francisella tularensis subspecies holarctica","volume":"35","author":"Stenmark","year":"2003","journal-title":"Microb. Pathog."},{"key":"B127","doi-asserted-by":"publisher","first-page":"ftw079","DOI":"10.1093\/femspd\/ftw079","article-title":"Respiratory and oral vaccination improves protection conferred by the live vaccine strain against pneumonic tularemia in the rabbit model","volume":"74","author":"Stinson","year":"2016","journal-title":"Pathog. Dis."},{"key":"B128","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1128\/IAI.60.6.2554-2558.1992","article-title":"Predominant expansion of V gamma 9\/V delta 2 T cells in a tularemia patient","volume":"60","author":"Sumida","year":"1992","journal-title":"Infect. Immun."},{"key":"B129","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1128\/IAI.59.6.1948-1953.1991","article-title":"Development of Francisella tularensis antigen responses measured as T-lymphocyte proliferation and cytokine production (tumor necrosis factor alpha, gamma interferon, and interleukin-2 and\u22124) during human tularemia","volume":"59","author":"Surcel","year":"1991","journal-title":"Infect. Immun."},{"key":"B130","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1093\/infdis\/153.1.142","article-title":"Agglutination and ELISA methods in the diagnosis of tularemia in different clinical forms and severities of the disease","volume":"153","author":"Syrj\u00e4l\u00e4","year":"1986","journal-title":"J. Infect. Dis."},{"key":"B131","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1093\/clinids\/11.3.440","article-title":"Nature of protective immunity to Francisella tularensis","volume":"11","author":"T\u00e4rnvik","year":"1989","journal-title":"Rev. Infect. Dis."},{"key":"B132","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/j.1574-695X.1996.tb00242.x","article-title":"Orchestration of the protective immune response to intracellular bacteria: Francisella tularensis as a model organism","volume":"13","author":"T\u00e4rnvik","year":"1996","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"B133","first-page":"329","article-title":"Host-parasite relationship in monkeys administered live tularemia vaccine","volume":"58","author":"Tulis","year":"1970","journal-title":"Am. J. Pathol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1354\/vp.08-VP-0302-T-AM","article-title":"Pathology of inhalational Francisella tularensis spp. tularensis SCHU S4 infection in African green monkeys (Chlorocebus aethiops)","volume":"46","author":"Twenhafel","year":"2009","journal-title":"Vet. Pathol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.bbrc.2006.06.008","article-title":"Immunoproteomic analysis of the murine antibody response to successful and failed immunization with live anti-Francisella vaccines","volume":"346","author":"Twine","year":"","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B136","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.micpath.2005.12.004","article-title":"Virulence comparison in mice of distinct isolates of type A Francisella tularensis","volume":"40","author":"Twine","year":"","journal-title":"Microb. Pathog."},{"key":"B137","doi-asserted-by":"publisher","first-page":"3634","DOI":"10.1016\/j.vaccine.2012.03.036","article-title":"BALB\/c mice, but not C57BL\/6 mice immunized with a DeltaclpB mutant of Francisella tularensis subspecies tularensis are protected against respiratory challenge with wild-type bacteria: association of protection with post-vaccination and post-challenge immune responses","volume":"30","author":"Twine","year":"2012","journal-title":"Vaccine"},{"key":"B138","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1016\/j.molimm.2009.01.008","article-title":"Identification of a dominant CD4 T cell epitope in the membrane lipoprotein Tul4 from Francisella tularensis LVS","volume":"46","author":"Valentino","year":"2009","journal-title":"Mol. Immunol."},{"key":"B139","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/j.1365-2567.2010.03387.x","article-title":"Identification of T-cell epitopes in Francisella tularensis using an ordered protein array of serological targets","volume":"132","author":"Valentino","year":"2011","journal-title":"Immunology"},{"key":"B140","first-page":"405","article-title":"Morphologic and immunohistochemical studies of the pathogenesis of infection and antibody formation subsequent to vaccination of Macaca irus with an attenuated strain of Pasteurella tularensis: II. Aerogenic vaccination","volume":"41","author":"White","year":"1962","journal-title":"Am. J. Pathol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fmicb.2013.00016","article-title":"Identification of Francisella novicida mutants that fail to induce prostaglandin E(2) synthesis by infected macrophages","volume":"4","author":"Woolard","year":"2013","journal-title":"Front. Microbiol."},{"key":"B142","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1128\/IAI.01412-07","article-title":"Respiratory Francisella tularensis live vaccine strain infection induces Th17 cells and prostaglandin E2, which inhibits generation of gamma interferon-positive T cells","volume":"76","author":"Woolard","year":"2008","journal-title":"Infect. Immun."},{"key":"B143","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.4049\/jimmunol.178.4.2065","article-title":"Francisella tularensis-infected macrophages release prostaglandin E2 that blocks T cell proliferation and promotes a Th2-like response","volume":"178","author":"Woolard","year":"2007","journal-title":"J. Immunol."},{"key":"B144","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1128\/IAI.73.5.2644-2654.2005","article-title":"Intranasal vaccination induces protective immunity against intranasal infection with virulent Francisella tularensis biovar A","volume":"73","author":"Wu","year":"2005","journal-title":"Infect. Immun."},{"key":"B145","doi-asserted-by":"publisher","first-page":"4684","DOI":"10.1016\/j.vaccine.2009.05.060","article-title":"Vaccination of Fischer 344 rats against pulmonary infections by Francisella tularensis type A strains","volume":"27","author":"Wu","year":"2009","journal-title":"Vaccine"},{"key":"B146","doi-asserted-by":"crossref","first-page":"5042","DOI":"10.4049\/jimmunol.157.11.5042","article-title":"Loss of either CD4+ or CD8+ T cells does not affect the magnitude of protective immunity to an intracellular pathogen, Francisella tularensis strain LVS","volume":"157","author":"Yee","year":"1996","journal-title":"J. Immunol."},{"key":"B147","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s10096-007-0434-x","article-title":"The presence of infectious extracellular Francisella tularensis subsp. novicida in murine plasma after pulmonary challenge","volume":"27","author":"Yu","year":"2008","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fcimb.2018.00115\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T20:06:40Z","timestamp":1720210000000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fcimb.2018.00115\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,6]]},"references-count":147,"alternative-id":["10.3389\/fcimb.2018.00115"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2018.00115","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,6]]},"article-number":"115"}}